CN105456911A - Drug for treating jaundice - Google Patents
Drug for treating jaundice Download PDFInfo
- Publication number
- CN105456911A CN105456911A CN201410466744.2A CN201410466744A CN105456911A CN 105456911 A CN105456911 A CN 105456911A CN 201410466744 A CN201410466744 A CN 201410466744A CN 105456911 A CN105456911 A CN 105456911A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- jaundice
- medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 206010023126 Jaundice Diseases 0.000 title claims abstract description 30
- 229940079593 drug Drugs 0.000 title claims abstract description 13
- 241000628997 Flos Species 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 6
- 241000222640 Polyporus Species 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 5
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract 2
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract 1
- 244000036905 Benincasa cerifera Species 0.000 abstract 1
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 241000245240 Lonicera Species 0.000 abstract 1
- 241001571764 Lysimachia christinae Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 4
- 206010058117 Ocular icterus Diseases 0.000 description 3
- 210000003786 sclera Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 2
- 229950010883 phencyclidine Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000024557 hepatobiliary disease Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a drug for treating jaundice. The drug is prepared from, by weight, 18-22 parts of poria cocos, 13-17 parts of seeds of Chinese waxgourd, 13-17 parts of rhizoma alismatis, 13-17 parts of honeysuckles, 13-17 parts of lysimachia christinae hance, 13-17 parts of eucommia ulmoides, 8-12 parts of radix bupleuri, 8-12 parts of radix curcumae and 8-12 parts of radix pseudostellariae. According to the treatment principles of nourishing yin for cooling blood, invigorating the spleen for eliminating dampness, and regulating vital energy for supporting yang, the traditional Chinese medicine composition is different from an existing Chinese medicinal formula for treating jaundice, and dialectics is adopted for carefully using herbs to form a prescription, so that all herbs achieve cooperative synergism. The composition achieves a remarkable curative effect on treating jaundice and is a pure traditional Chinese medicine preparation with a small side effect.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specially a kind of medicine for the treatment of jaundice.
Background technology
Jaundice is common sympton and sign, and it to cause in serum caused by bilirubin concentration raises.Clinical signs is that sclera, mucosa, skin and hetero-organization thereof are dyed to yellow.Because sclera contains more elasticin, have stronger affinity with bilirubin, therefore Patients with Jaundice yellow sclera is often prior to mucosa, skin and first being discovered.When serum total bilirubin is at 17.1 ~ 34.2 μm of ol/L, and when naked eyes do not see jaundice, claim latent jaundice or subclinical jaundice; When bloodstain total bilirubin concentration is more than 34.2 μm of ol/L, jaundice can be found clinically, also referred to as clinical jaundice.
Chinese medicine is thought damp and hot pathogenic factor is experienced by jaundice system, retardance liver and gall, mechanism of qi is obstructed, and catharsis is not normal, caused by bile is excessive.With the disease that icteric sclera, yellowish body, yellow urine are main clinical manifestation, be more common in hepatobiliary system disease.Common syndrome mainly contains following four class syndrome-classification dampness-heat in the liver and gallbladder, the spleen and stomach being stranded by dampness, excessive noxious heat and cold coagulation sun and declines.
Summary of the invention
The object of the invention is, in order to overcome above-mentioned the deficiencies in the prior art part, to provide a kind of medicine for the treatment of jaundice according to phencyclidine, invigorating the spleen for eliminating dampness and supporing yang Chinese medical theory of regulating the flow of vital energy.
The medicine that the present invention treats jaundice is the medicament be made up of the crude drug of following parts by weight:
Poria 18-22 part, Semen Benincasae 13-17 part, Rhizoma Alismatis 13-17 part, Flos Lonicerae 13-17 part, Herba Lysimachiae 13-17 part, Cortex Eucommiae 13-17 part, Radix Bupleuri 8-12 part, Radix Curcumae 8-12 part and Radix Pseudostellariae 8-12 part.
Further, it is the medicament be made up of the crude drug of following parts by weight: 18 parts, Poria, Semen Benincasae 13 parts, Rhizoma Alismatis 13 parts, Flos Lonicerae 13 parts, Herba Lysimachiae 13 parts, the Cortex Eucommiae 13 parts, Radix Bupleuri 8 parts, Radix Curcumae 8 parts and Radix Pseudostellariae 8 parts.
Further, it is the medicament be made up of the crude drug of following parts by weight: 22 parts, Poria, Semen Benincasae 17 parts, Rhizoma Alismatis 17 parts, Flos Lonicerae 17 parts, Herba Lysimachiae 17 parts, the Cortex Eucommiae 17 parts, Radix Bupleuri 12 parts, Radix Curcumae 12 parts and Radix Pseudostellariae 12 parts.
Further, it is the medicament be made up of the crude drug of following parts by weight: 20 parts, Poria, Semen Benincasae 15 parts, Rhizoma Alismatis 15 parts, Flos Lonicerae 15 parts, Herba Lysimachiae 15 parts, the Cortex Eucommiae 15 parts, Radix Bupleuri 10 parts, Radix Curcumae 10 parts and Radix Pseudostellariae 10 parts.
Further, described medicament also comprises Radix Scrophulariae 20 parts, Semen Plantaginis 15 parts, Polyporus 15 parts, Herba Dianthi 15 Fen, Herba Polygoni Avicularis 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, Medulla Tetrapanacis 10 parts and Radix Aconiti Lateralis Preparata 6 parts
Further, described medicament is capsule.
Further, described Radix Aconiti Lateralis Preparata is Radix Aconiti Lateralis Preparata.
Chinese medicine composition provided by the invention, with phencyclidine, invigorating the spleen for eliminating dampness and regulate the flow of vital energy supporing yang for Therapeutic Principle, be different from the Chinese medicinal formulae of existing treatment jaundice, then rigorous using drugs to form a prescription is carried out according to dialectical, make each taste medicine Synergistic, this compound recipe achieves the curative effect showed in treatment jaundice, and the present invention is that pure Chinese medicinal preparation side effect is less.
Detailed description of the invention
Treat a medicine for jaundice, be made up of following bulk drugs:
Poria 20g, Semen Benincasae 15g, Rhizoma Alismatis 15g, Flos Lonicerae 15g, Herba Lysimachiae 15g, Cortex Eucommiae 15g, Radix Bupleuri 10g, Radix Curcumae 10g, Radix Pseudostellariae 10g, Radix Scrophulariae 20g, Semen Plantaginis 15g, Polyporus 15g, Herba Dianthi 15g, Herba Polygoni Avicularis 15g, Rhizoma Atractylodis Macrocephalae 15g, Medulla Tetrapanacis 10g and Radix Aconiti Lateralis Preparata 6g.
After being mixed by above-mentioned raw materials medicine, be dried and crushed into fine flour, cross 300 mesh sieves, incapsulate.Every capsule has above-mentioned raw materials medicine 0.6g.
Instructions of taking: the people of more than 18 years old three times on the one, each 2.Within 30 days, be a course for the treatment of, take six courses for the treatment of continuously.As taken 1 month symptom continuously without obviously changing or occurring side effect after taking medicine, should drug withdrawal immediately.
Clinical trial:
1. the diagnostic criteria of case selection
1 icteric sclera, skin are yellow, yellowish urine, based on icteric sclera.2 from the beginning of there being fever with aversion to cold, indigestion and loss of appetitely detests oil, nausea and vomiting, spiritlessness and weakness, or stool color is thin out.Jaundice severe patient skin pruritus.3 have eating and drinking without temperance, the medical histories such as hepatitis contact or applied chemistry goods medicine.4 livers, spleen or gollbladder dilation, with tenderness or tenderness.5. get rid of the malignant changes such as liver, gallbladder, pancreas.
According to above-mentioned standard choose patient 100 example, man 54 example, female 46 example, age 18-60 year.
2. efficacy assessment standard
Cure: jaundice disappears, and other transference cures, lab index is normal.
Take a turn for the better: jaundice and other symptoms alleviate, bilirubin is normal or reduce, and other lab index take a turn for the better.
Do not heal: jaundice is not moved back or deepened, other symptoms and lab index are without improvement.
3. data result statistical analysis
After taking, 71 examples are cured, and 24 examples take a turn for the better, and 5 examples do not heal.Within six months, observe through transmission from one meridian to another again and there is no obvious untoward reaction.
Claims (7)
1. treat a medicine for jaundice, it is characterized in that it is the medicament be made up of the crude drug of following parts by weight: Poria 18-22 part, Semen Benincasae 13-17 part, Rhizoma Alismatis 13-17 part, Flos Lonicerae 13-17 part, Herba Lysimachiae 13-17 part, Cortex Eucommiae 13-17 part, Radix Bupleuri 8-12 part, Radix Curcumae 8-12 part and Radix Pseudostellariae 8-12 part.
2. the medicine for the treatment of jaundice according to claim 1, is characterized in that it is the medicament be made up of the crude drug of following parts by weight: 18 parts, Poria, Semen Benincasae 13 parts, Rhizoma Alismatis 13 parts, Flos Lonicerae 13 parts, Herba Lysimachiae 13 parts, the Cortex Eucommiae 13 parts, Radix Bupleuri 8 parts, Radix Curcumae 8 parts and Radix Pseudostellariae 8 parts.
3. the medicine for the treatment of jaundice according to claim 1 and 2, is characterized in that it is the medicament be made up of the crude drug of following parts by weight: 22 parts, Poria, Semen Benincasae 17 parts, Rhizoma Alismatis 17 parts, Flos Lonicerae 17 parts, Herba Lysimachiae 17 parts, the Cortex Eucommiae 17 parts, Radix Bupleuri 12 parts, Radix Curcumae 12 parts and Radix Pseudostellariae 12 parts.
4. the medicine for the treatment of jaundice according to claim 1, is characterized in that it is the medicament be made up of the crude drug of following parts by weight: 20 parts, Poria, Semen Benincasae 15 parts, Rhizoma Alismatis 15 parts, Flos Lonicerae 15 parts, Herba Lysimachiae 15 parts, the Cortex Eucommiae 15 parts, Radix Bupleuri 10 parts, Radix Curcumae 10 parts and Radix Pseudostellariae 10 parts.
5. the medicine of the treatment jaundice according to claim 1 or 4, is characterized in that described medicament also comprises Radix Scrophulariae 20 parts, Semen Plantaginis 15 parts, Polyporus 15 parts, Herba Dianthi 15 Fen, Herba Polygoni Avicularis 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, Medulla Tetrapanacis 10 parts and Radix Aconiti Lateralis Preparata 6 parts
6. the medicine for the treatment of jaundice as claimed in any of claims 1 to 5, is characterized in that described medicament is capsule.
7. the medicine for the treatment of jaundice as claimed in any of claims 1 to 6, is characterized in that described Radix Aconiti Lateralis Preparata is Radix Aconiti Lateralis Preparata.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410466744.2A CN105456911A (en) | 2014-09-13 | 2014-09-13 | Drug for treating jaundice |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410466744.2A CN105456911A (en) | 2014-09-13 | 2014-09-13 | Drug for treating jaundice |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105456911A true CN105456911A (en) | 2016-04-06 |
Family
ID=55595360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410466744.2A Pending CN105456911A (en) | 2014-09-13 | 2014-09-13 | Drug for treating jaundice |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105456911A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060002886A1 (en) * | 2002-01-28 | 2006-01-05 | Schur Henry B | Waste water treatment biocatalyst - CIP |
| CN101152539A (en) * | 2007-09-24 | 2008-04-02 | 梁平 | Traditional Chinese medicine for treating acute icteric hepatitis |
-
2014
- 2014-09-13 CN CN201410466744.2A patent/CN105456911A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060002886A1 (en) * | 2002-01-28 | 2006-01-05 | Schur Henry B | Waste water treatment biocatalyst - CIP |
| CN101152539A (en) * | 2007-09-24 | 2008-04-02 | 梁平 | Traditional Chinese medicine for treating acute icteric hepatitis |
Non-Patent Citations (1)
| Title |
|---|
| 张学明等: "《肝病金方666》", 28 February 1999, 河北科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103040960A (en) | Traditional Chinese medicine formula for treating high blood pressure | |
| CN103784570A (en) | Chinese herbal preparation for treating neonatal jaundice | |
| CN102961674B (en) | Chinese medicinal composition for treating jaundice | |
| CN103919966B (en) | A kind of medicine treating acne | |
| CN103356925B (en) | Traditional Chinese medicine composition for treating sperm non-liquified symptom | |
| CN104800799B (en) | It is a kind of to treat Chinese medicine of the endometrial thickness with ovarian cyst | |
| CN104667249B (en) | A kind of Chinese medicine composition for treating primary dysmenorrhea | |
| CN103638485A (en) | Chinese medicinal composition for treating dyspepsia of hepatopathy patients | |
| CN105456911A (en) | Drug for treating jaundice | |
| CN105288452A (en) | Preparation method of medicine for treating jaundice | |
| CN103301368B (en) | Medicament for treating hyperactivity | |
| CN103432533B (en) | Traditional Chinese medicine for treating perianal abscess | |
| CN106492175A (en) | A kind of Chinese medicine for treating stagnation of liver-QI with deficiency of the spleen | |
| CN104825714A (en) | Traditional Chinese medicine for treating constipation | |
| CN104971302A (en) | Traditional Chinese medicine composition for treating biliary tract ascariasis | |
| CN103100002A (en) | Medicament for treating acute herpes zoster caused by retention of damp-heat in the interior | |
| CN103961391B (en) | A kind of pharmaceutical composition treating gastrointestinal neurosis | |
| CN103463337B (en) | Traditional Chinese medicine for treating axillary acute purulent lymphadenitis caused by blockage of channels and collaterals | |
| CN102302589A (en) | Chinese medicinal composition for treating diarrhea irritable bowel syndrome and preparation method thereof | |
| CN102085350A (en) | Medicament for treating arthritis and preparation method thereof | |
| CN108295168A (en) | A kind of Chinese medicine composition for treating Poststroke Depression | |
| CN106075268A (en) | A kind of Chinese medicine composition treating scabies | |
| CN103768430A (en) | Traditional Chinese medicinal composition for treating gastric ulcer | |
| CN117414390A (en) | Traditional Chinese medicine compositions, preparations and preparation methods for treating allergic purpura in children | |
| CN105727180A (en) | Chinese herbal medicine composition for treating mammary gland hyperplasia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160406 |
|
| WD01 | Invention patent application deemed withdrawn after publication |